Drug Shortage Report for ALTACE

Last updated on 2020-02-14 History
Report ID 104130
Drug Identification Number 02221829
Brand name ALTACE
Common or Proper name ALTACE
Company Name VALEANT CANADA LP/VALEANT CANADA S.E.C.
Active Ingredient(s) RAMIPRIL
Strength(s) 1.25MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 30 caps
ATC code C09AA
ATC description ACE INHIBITORS, PLAIN
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-01-10
Estimated end date
Actual end date 2020-02-10
Shortage status Resolved
Updated date 2020-02-14
Company comments delay in production
Health Canada comments
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-02-14 French Compare
v3 2020-02-14 English Compare
v2 2020-01-23 French Compare
v1 2020-01-23 English Compare